Plasma proteomics of <i>APOE</i> genotype: age-specific analyses in UK population-based cohorts

Background: ε2 carriage on the circulating proteome in middle-age and later life. Methods: -associated proteins in age-matched groups, using data from two independent UK-based cohorts. Results: = 40,092); 130 of these were associated with both ε2 and ε4 carriage (with either consistent or inverse association directions). These included established biomarkers of neurodegeneration (GFAP and NEFL) and other proteins implicated by AD genetic risk loci (e.g., TREM2, CTSB, IDUA, SORT1, GRN). Many of these proteins are linked to other neurodegenerative diseases besides AD. In multiple age groups, ε4 carriage was strongly associated with consistent differences in circulating APOE, MENT, and PLA2G7 levels across ancestries and cohorts. Conclusion: ε4 and ε2 exert broad, often age-dependent effects on the plasma proteome, detectable decades before typical ages of AD diagnoses, highlighting a potential early window for monitoring and intervention.

Authors

Institutions

Publication Details

Journal
medRxiv
Published
2026-04-17
DOI
https://doi.org/10.64898/2026.04.16.26351010
Primary Topic
Alzheimer's disease research and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Plasma proteomics of APOE genotype: age-specific analyses in UK population-based cohorts

Petroula Proitsi, Tony Wyss‐Coray, Amy E. Packer, D Lines Williams et al.
medRxiv
Alzheimer's disease research and treatments
article

Plasma proteomics of APOE genotype: age-specific analyses in UK population-based cohorts

Petroula Proitsi, Tony Wyss‐Coray, Amy E. Packer, D Lines Williams, Jonathan Schott, Tahsin Khatun, James William Groves, Emma L Anderson
article en

Abstract

Background: ε2 carriage on the circulating proteome in middle-age and later life. Methods: -associated proteins in age-matched groups, using data from two independent UK-based cohorts. Results: = 40,092); 130 of these were associated with both ε2 and ε4 carriage (with either consistent or inverse association directions). These included established biomarkers of neurodegeneration (GFAP and NEFL) and other proteins implicated by AD genetic risk loci (e.g., TREM2, CTSB, IDUA, SORT1, GRN). Many of these proteins are linked to other neurodegenerative diseases besides AD. In multiple age groups, ε4 carriage was strongly associated with consistent differences in circulating APOE, MENT, and PLA2G7 levels across ancestries and cohorts. Conclusion: ε4 and ε2 exert broad, often age-dependent effects on the plasma proteome, detectable decades before typical ages of AD diagnoses, highlighting a potential early window for monitoring and intervention.

medRxiv
Queen Mary University of London (GB), King's College London (GB), Neurosciences Institute (US), UK Dementia Research Institute (GB), MRC Unit for Lifelong Health and Ageing (GB), National Hospital for Neurology and Neurosurgery (GB), University College London (GB), Stanford University (US)
Openalex Percentile: Top 25%
Alzheimer's disease research and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.